Volume 52, Number 5, 986-987, DOI: 10.1007/s00125-009-1301-3

Published in partnership with the

Logo

European Association for the Study of Diabetes

GlaxoSmithKline responds to the consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

P. Ambery and A. R. Cobitz

View Related Documents

Abstract

Fulltext Preview

Image of the first page of the fulltext document